BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology. 1998;114:344-351. [PMID: 9453496 DOI: 10.1016/s0016-5085(98)70487-1] [Cited by in Crossref: 297] [Cited by in F6Publishing: 82] [Article Influence: 12.4] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E, Sauerbruch T, Heller J. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut. 2006;55:1296-1305. [PMID: 16492715 DOI: 10.1136/gut.2005.081059] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
2 Tripathi D, Therapondos G, Ferguson JW, Newby DE, Webb DJ, Hayes PC. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial. Gut. 2006;55:1290-1295. [PMID: 16434427 DOI: 10.1136/gut.2005.077453] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
3 Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016;51:511-519. [PMID: 26939970 DOI: 10.1007/s00535-016-1190-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
4 Yu Q, Shao R, Qian HS, George SE, Rockey DC. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest. 2000;105:741-748. [PMID: 10727442 DOI: 10.1172/jci7997] [Cited by in Crossref: 117] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
5 Kim RG, Loomba R, Prokop LJ, Singh S. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2017; 15: 1521-1530. e8. [PMID: 28479502 DOI: 10.1016/j.cgh.2017.04.039] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 12.2] [Reference Citation Analysis]
6 Van De Casteele M, Van Pelt JF, Nevens F, Fevery J, Reichen J. Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls. Comp Hepatol 2003;2:2. [PMID: 12575897 DOI: 10.1186/1476-5926-2-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
7 Pereira ENGDS, Silvares RR, Flores EEI, Rodrigues KL, Ramos IP, da Silva IJ, Machado MP, Miranda RA, Pazos-Moura CC, Gonçalves-de-Albuquerque CF, Faria-Neto HCC, Tibiriça E, Daliry A. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease. PLoS One 2017;12:e0179654. [PMID: 28628674 DOI: 10.1371/journal.pone.0179654] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
8 García-Fernández M, Castilla-Cortázar I, Díaz-Sanchez M, Navarro I, Puche JE, Castilla A, Casares AD, Clavijo E, González-Barón S. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol 2005;5:7. [PMID: 15745444 DOI: 10.1186/1471-230X-5-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
9 Watanabe N, Takashimizu S, Nishizaki Y, Kojima S, Kagawa T, Matsuzaki S. An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation. J Gastroenterol. 2007;42:775-782. [PMID: 17876548 DOI: 10.1007/s00535-007-2093-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
10 Liu S, Premont RT, Rockey DC. G-protein-coupled receptor kinase interactor-1 (GIT1) is a new endothelial nitric-oxide synthase (eNOS) interactor with functional effects on vascular homeostasis. J Biol Chem. 2012;287:12309-12320. [PMID: 22294688 DOI: 10.1074/jbc.m111.320465] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
11 Xu R, Yuan YF, Ayav A, Jiang CQ, Bresler L, Liu ZS, Tran N. Effect of portal vein ligation on tumor growth and liver regeneration in rat cirrhotic liver lobes. Exp Ther Med 2014;7:1089-94. [PMID: 24940392 DOI: 10.3892/etm.2014.1607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Palmes D, Minin E, Budny T, Uhlmann D, Armann B, Stratmann U, Herbst H, Spiegel HU. The endothelin/nitric oxide balance determines small-for-size liver injury after reduced-size rat liver transplantation. Virchows Arch. 2005;447:731-741. [PMID: 16012845 DOI: 10.1007/s00428-005-0006-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
13 Sarela AI, Mihaimeed FM, Batten JJ, Davidson BR, Mathie RT. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut. 1999;44:749-753. [PMID: 10205218 DOI: 10.1136/gut.44.5.749] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 3.5] [Reference Citation Analysis]
14 Xie G, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, Gaarde WA, Deleve LD. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology 2012; 142: 918-927. e6. [PMID: 22178212 DOI: 10.1053/j.gastro.2011.12.017] [Cited by in Crossref: 190] [Cited by in F6Publishing: 173] [Article Influence: 17.3] [Reference Citation Analysis]
15 Bolognesi M, Di Pascoli M, Verardo A, Gatta A. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol 2014; 20(10): 2555-2563 [PMID: 24627591 DOI: 10.3748/wjg.v20.i10.2555] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 84] [Article Influence: 13.3] [Reference Citation Analysis]
16 Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells 2020;9:E929. [PMID: 32290100 DOI: 10.3390/cells9040929] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
17 Chen Y, Yuan S, Cao Y, Kong G, Jiang F, Li Y, Wang Q, Tang M, Zhang Q, Wang Q, Liu L. Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases. Oxid Med Cell Longev 2021;2021:3206982. [PMID: 34594474 DOI: 10.1155/2021/3206982] [Reference Citation Analysis]
18 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Liu S, Premont RT, Rockey DC. Endothelial nitric-oxide synthase (eNOS) is activated through G-protein-coupled receptor kinase-interacting protein 1 (GIT1) tyrosine phosphorylation and Src protein. J Biol Chem. 2014;289:18163-18174. [PMID: 24764294 DOI: 10.1074/jbc.m113.521203] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
20 Thabut D, Routray C, Lomberk G, Shergill U, Glaser K, Huebert R, Patel L, Masyuk T, Blechacz B, Vercnocke A, Ritman E, Ehman R, Urrutia R, Shah V. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology. 2011;54:573-585. [PMID: 21567441 DOI: 10.1002/hep.24427] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
21 Snowdon VK, Guha N, Fallowfield JA. Noninvasive evaluation of portal hypertension: emerging tools and techniques. Int J Hepatol. 2012;2012:691089. [PMID: 22720166 DOI: 10.1155/2012/691089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
22 Lluch P, Segarra G, Medina P. Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis. World J Gastroenterol 2015; 21(32): 9466-9475 [PMID: 26327755 DOI: 10.3748/wjg.v21.i32.9466] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
23 Gandhi CR, Uemura T, Kuddus R. Endotoxin causes up-regulation of endothelin receptors in cultured hepatic stellate cells via nitric oxide-dependent and -independent mechanisms. Br J Pharmacol 2000;131:319-27. [PMID: 10991926 DOI: 10.1038/sj.bjp.0703577] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
24 Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol. 2014;61:912-924. [PMID: 24911462 DOI: 10.1016/j.jhep.2014.05.047] [Cited by in Crossref: 162] [Cited by in F6Publishing: 141] [Article Influence: 20.3] [Reference Citation Analysis]
25 Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Christos P, Paraskevi K, Konstantinos P, Katsaraki A, Tsianos EV. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Dig Dis Sci. 2005;50:1771-1777. [PMID: 16187171 DOI: 10.1007/s10620-005-2935-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
26 Gracia-Sancho J, Maeso-Díaz R, Fernández-Iglesias A, Navarro-Zornoza M, Bosch J. New cellular and molecular targets for the treatment of portal hypertension. Hepatol Int. 2015;9:183-191. [PMID: 25788198 DOI: 10.1007/s12072-015-9613-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
27 Kim MY, Baik SK, Lee SS. Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol 2010;16:347-52. [PMID: 21415576 DOI: 10.3350/kjhep.2010.16.4.347] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
28 Theodorakis NG, Wang YN, Korshunov VA, Maluccio MA, Skill NJ. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure. World J Gastroenterol 2015; 21(14): 4126-4135 [PMID: 25892862 DOI: 10.3748/wjg.v21.i14.4126] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 González-Abraldes J, García-Pagán JC, Bosch J. Nitric oxide and portal hypertension. Metab Brain Dis. 2002;17:311-324. [PMID: 12602508 DOI: 10.1023/a:1021957818240] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
30 Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20:8072-8081. [PMID: 25009379 DOI: 10.3748/wjg.v20.i25.80729] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Gao K, Liu F, Chen X, Chen M, Deng Q, Zou X, Guo H. Crocetin protects against fulminant hepatic failure induced by lipopolysaccharide/D-galactosamine by decreasing apoptosis, inflammation and oxidative stress in a rat model. Exp Ther Med. 2019;18:3775-3782. [PMID: 31616509 DOI: 10.3892/etm.2019.8030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Iwasaki J, Afify M, Bleilevens C, Klinge U, Weiskirchen R, Steitz J, Vogt M, Yagi S, Nagai K, Uemoto S, Tolba RH. The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats. Int J Mol Sci 2019;20:E2114. [PMID: 31035686 DOI: 10.3390/ijms20092114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Li Y, Liu H, Gaskari SA, McCafferty DM, Lee SS. Hepatic venous dysregulation contributes to blood volume pooling in cirrhotic rats. Gut 2006;55:1030-5. [PMID: 16401688 DOI: 10.1136/gut.2005.082446] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
34 Møller S, Henriksen JH. Cardiopulmonary complications in chronic liver disease. World J Gastroenterol 2006; 12(4): 526-538 [PMID: 16489664 DOI: 10.3748/wjg.v12.i4.526] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
35 Bravo M, Raurell I, Hide D, Fernández-Iglesias A, Gil M, Barberá A, Salcedo MT, Augustin S, Genescà J, Martell M. Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH. Sci Rep 2019;9:20183. [PMID: 31882668 DOI: 10.1038/s41598-019-56366-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
36 Vorobioff J, Groszmann R. Portal Hypertension—Molecular Mechanisms. Liver Pathophysiology. Elsevier; 2017. pp. 435-49. [DOI: 10.1016/b978-0-12-804274-8.00034-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Mookerjee RP, Mehta G, Balasubramaniyan V, Mohamed Fel Z, Davies N, Sharma V, Iwakiri Y, Jalan R. Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension. J Hepatol. 2015;62:325-331. [PMID: 25152204 DOI: 10.1016/j.jhep.2014.08.024] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
38 Kimer N, Grønbæk H, Fred RG, Hansen T, Deshmukh AS, Mann M, Bendtsen F. Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial. BMJ Open 2020;10:e035284. [PMID: 31980514 DOI: 10.1136/bmjopen-2019-035284] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Shetty S, Lalor PF, Adams DH. Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity. Nat Rev Gastroenterol Hepatol. 2018;15:555-567. [PMID: 29844586 DOI: 10.1038/s41575-018-0020-y] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 30.3] [Reference Citation Analysis]
40 Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World J Gastroenterol 2006; 12(41): 6639-6645 [PMID: 17075977 DOI: 10.3748/wjg.v12.i41.6639] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
41 Xie G, Choi SS, Syn WK, Michelotti GA, Swiderska M, Karaca G, Chan IS, Chen Y, Diehl AM. Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation. Gut. 2013;62:299-309. [PMID: 22362915 DOI: 10.1136/gutjnl-2011-301494] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 6.8] [Reference Citation Analysis]
42 Liu S, Premont RT, Singh S, Rockey DC. Caveolin 1 and G-Protein-Coupled Receptor Kinase-2 Coregulate Endothelial Nitric Oxide Synthase Activity in Sinusoidal Endothelial Cells. Am J Pathol 2017;187:896-907. [PMID: 28162981 DOI: 10.1016/j.ajpath.2016.11.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
43 Cunningham RP, Sheldon RD, Rector RS. The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development. Front Physiol 2020;11:767. [PMID: 32719616 DOI: 10.3389/fphys.2020.00767] [Reference Citation Analysis]
44 Shafiei MS, Lui S, Rockey DC. Integrin-linked kinase regulates endothelial cell nitric oxide synthase expression in hepatic sinusoidal endothelial cells. Liver Int. 2014;Jun 6. [Epub ahead of print]. [PMID: 24906011 DOI: 10.1111/liv. 12606] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Hall KC, Bernier SG, Jacobson S, Liu G, Zhang PY, Sarno R, Catanzano V, Currie MG, Masferrer JL. sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. Proc Natl Acad Sci U S A 2019;116:11057-62. [PMID: 31085647 DOI: 10.1073/pnas.1821045116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
46 Persico M, Masarone M, Damato A, Ambrosio M, Federico A, Rosato V, Bucci T, Carrizzo A, Vecchione C. "Non alcoholic fatty liver disease and eNOS dysfunction in humans". BMC Gastroenterol 2017;17:35. [PMID: 28264657 DOI: 10.1186/s12876-017-0592-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
47 DeLeve LD, Maretti-Mira AC. Liver Sinusoidal Endothelial Cell: An Update. Semin Liver Dis 2017;37:377-87. [PMID: 29272898 DOI: 10.1055/s-0037-1617455] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
48 Wei CL, Hon WM, Lee KH, Khoo HE. Temporal expression of hepatic inducible nitric oxide synthase in liver cirrhosis. World J Gastroenterol 2005; 11(3): 362-367 [PMID: 15637745 DOI: 10.3748/wjg.v11.i3.362] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
49 Li T, Yang Z. Research progress of vasculopathy in portal hypertension. World J Gastroenterol 2005; 11(39): 6079-6084 [PMID: 16273630 DOI: 10.3748/wjg.v11.i39.6079] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
50 Feng HQ, Weymouth ND, Rockey DC. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. Am J Physiol Gastrointest Liver Physiol. 2009;297:G27-G33. [PMID: 19299580 DOI: 10.1152/ajpgi.90405.2008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
51 Gurevich EV, Tesmer JJ, Mushegian A, Gurevich VV. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther. 2012;133:40-69. [PMID: 21903131 DOI: 10.1016/j.pharmthera.2011.08.001] [Cited by in Crossref: 275] [Cited by in F6Publishing: 256] [Article Influence: 25.0] [Reference Citation Analysis]
52 Jayakumar Amirtharaj G, Thangaraj KR, Kini A, V R, Goel A, C E E, Venkatraman A, Pulimood AB, K A B, Ramachandran A. Acute liver injury induced by low dose dimethylnitrosamine alters mediators of hepatic vascular flow. Toxicol Rep 2014;1:707-17. [PMID: 28962284 DOI: 10.1016/j.toxrep.2014.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Fiorucci S, Antonelli E, Morelli O, Mencarelli A, Casini A, Mello T, Palazzetti B, Tallet D, del Soldato P, Morelli A. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A 2001;98:8897-902. [PMID: 11447266 DOI: 10.1073/pnas.151136298] [Cited by in Crossref: 98] [Cited by in F6Publishing: 81] [Article Influence: 4.7] [Reference Citation Analysis]
54 Semela D, Das A, Langer D, Kang N, Leof E, Shah V. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function. Gastroenterology. 2008;135:671-679. [PMID: 18570897 DOI: 10.1053/j.gastro.2008.04.010] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 7.6] [Reference Citation Analysis]
55 Wu T, Shah V. Biomarkers of endothelial dysfunction in alcoholic hepatitis. Hepatol Int 2021;15:855-7. [PMID: 34043159 DOI: 10.1007/s12072-021-10202-w] [Reference Citation Analysis]
56 Wilkinson AL, Qurashi M, Shetty S. The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Front Physiol 2020;11:990. [PMID: 32982772 DOI: 10.3389/fphys.2020.00990] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
57 Das A, Mukherjee P, Singla SK, Guturu P, Frost MC, Mukhopadhyay D, Shah VH, Patra CR. Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide. Nanotechnology. 2010;21:305102. [PMID: 20610873 DOI: 10.1088/0957-4484/21/30/305102] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
58 Sheldon RD, Laughlin MH, Rector RS. Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats. J Appl Physiol (1985) 2014;116:1156-64. [PMID: 24577062 DOI: 10.1152/japplphysiol.01275.2013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
59 Maretti-Mira AC, Wang X, Wang L, DeLeve LD. Incomplete Differentiation of Engrafted Bone Marrow Endothelial Progenitor Cells Initiates Hepatic Fibrosis in the Rat. Hepatology 2019;69:1259-72. [PMID: 30141211 DOI: 10.1002/hep.30227] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
60 DeLeve LD. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology. 2015;61:1740-1746. [PMID: 25131509 DOI: 10.1002/hep.27376] [Cited by in Crossref: 197] [Cited by in F6Publishing: 181] [Article Influence: 28.1] [Reference Citation Analysis]
61 Qiu YD, Wang S, Yang Y, Yan XP. Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats. World J Gastroenterol 2012; 18(25): 3288-3295 [PMID: 22783054 DOI: 10.3748/wjg.v18.i25.3288] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
62 Soon RK, Yee HF. Stellate cell contraction: role, regulation, and potential therapeutic target. Clin Liver Dis. 2008;12:791-803, viii. [PMID: 18984467 DOI: 10.1016/j.cld.2008.07.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
63 Taguchi K, Matsumoto T, Kobayashi T. G-protein-coupled receptor kinase 2 and endothelial dysfunction: molecular insights and pathophysiological mechanisms. J Smooth Muscle Res 2015;51:37-49. [PMID: 26447102 DOI: 10.1540/jsmr.51.37] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
64 Xie G, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, Gaarde WA, Deleve LD. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology. 2012;142:918-927.e6. [PMID: 22178212 DOI: 10.1053/j.gas tro.2011.12.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 McConnell M, Iwakiri Y. Biology of portal hypertension. Hepatol Int. 2018;12:11-23. [PMID: 29075990 DOI: 10.1007/s12072-017-9826-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
66 Warner J, Hardesty J, Zirnheld K, McClain C, Warner D, Kirpich I. Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps. Biology (Basel) 2020;9:E124. [PMID: 32545637 DOI: 10.3390/biology9060124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Frossard JL, Quadri R, Hadengue A, Morel P, Pastor CM. Endothelial nitric oxide synthase regulation is altered in pancreas from cirrhotic rats. World J Gastroenterol 2006; 12(2): 228-233 [PMID: 16482622 DOI: 10.3748/wjg.v12.i2.228] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Van de Casteele M, Omasta A, Janssens S, Roskams T, Desmet V, Nevens F, Fevery J. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats. Gut. 2002;51:440-445. [PMID: 12171971 DOI: 10.1136/gut.51.3.440] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
69 Copp SW, Hirai DM, Schwagerl PJ, Musch TI, Poole DC. Effects of neuronal nitric oxide synthase inhibition on resting and exercising hindlimb muscle blood flow in the rat. J Physiol 2010;588:1321-31. [PMID: 20176629 DOI: 10.1113/jphysiol.2009.183723] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
70 Ruart M, Chavarria L, Campreciós G, Suárez-herrera N, Montironi C, Guixé-muntet S, Bosch J, Friedman SL, Garcia-pagán JC, Hernández-gea V. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. Journal of Hepatology 2019;70:458-69. [DOI: 10.1016/j.jhep.2018.10.015] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
71 Singh S, Liu S, Rockey DC. Caveolin-1 is upregulated in hepatic stellate cells but not sinusoidal endothelial cells after liver injury. Tissue Cell 2016;48:126-32. [PMID: 26847875 DOI: 10.1016/j.tice.2015.12.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
72 Shenoda B, Boselli J. Vascular syndromes in liver cirrhosis. Clin J Gastroenterol 2019;12:387-97. [PMID: 30980261 DOI: 10.1007/s12328-019-00956-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
73 Sakurai S, Kojima H, Uemura M, Satoh H, Fukui H. Local regulator adrenomedullin contributes to the circulatory disturbance in cirrhotic rats. World J Gastroenterol 2006; 12(13): 2095-2102 [PMID: 16610064 DOI: 10.3748/wjg.v12.i13.2095] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
74 Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol 2014; 20(25): 8072-8081 [PMID: 25009379 DOI: 10.3748/wjg.v20.i25.8072] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
75 Martell M, Coll M, Ezkurdia N, Raurell I, Genescà J. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 2010; 2(6): 208-220 [PMID: 21160999 DOI: 10.4254/wjh.v2.i6.208] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
76 Natarajan V, Harris EN, Kidambi S. SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis. Biomed Res Int. 2017;2017:4097205. [PMID: 28293634 DOI: 10.1155/2017/4097205] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
77 Wan S, Huang C, Zhu X. Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients. BMJ Open 2019;9:e030038. [PMID: 31315875 DOI: 10.1136/bmjopen-2019-030038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
78 Liu S, Rockey DC. Cicletanine stimulates eNOS phosphorylation and NO production via Akt and MAP kinase/Erk signaling in sinusoidal endothelial cells. Am J Physiol Gastrointest Liver Physiol. 2013;305:G163-G171. [PMID: 23639812 DOI: 10.1152/ajpgi.00003.2013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
79 Yi S, Qin X, Luo X, Zhang Y, Liu Z, Zhu L. Identification of miRNAs associated with the mechanical response of hepatic stellate cells by miRNA microarray analysis. Exp Ther Med 2018;16:1707-14. [PMID: 30186391 DOI: 10.3892/etm.2018.6384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
80 Huang YW, Lee CL, Yang SS, Fu SC, Chen YY, Wang TC, Hu JT, Chen DS. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study. Am J Gastroenterol. 2016;111:976-985. [PMID: 27166128 DOI: 10.1038/ajg.2016.179] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
81 Shafiei MS, Lui S, Rockey DC. Integrin-linked kinase regulates endothelial cell nitric oxide synthase expression in hepatic sinusoidal endothelial cells. Liver Int. 2015;35:1213-1221. [PMID: 24906011 DOI: 10.1111/liv.12606] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
82 De Smedt J, van Os EA, Talon I, Ghosh S, Toprakhisar B, Furtado Madeiro Da Costa R, Zaunz S, Vazquez MA, Boon R, Baatsen P, Smout A, Verhulst S, van Grunsven LA, Verfaillie CM. PU.1 drives specification of pluripotent stem cell-derived endothelial cells to LSEC-like cells. Cell Death Dis 2021;12:84. [PMID: 33446637 DOI: 10.1038/s41419-020-03356-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
83 Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut. 2002;50:571-581. [PMID: 11889082 DOI: 10.1136/gut.50.4.571] [Cited by in Crossref: 194] [Cited by in F6Publishing: 185] [Article Influence: 9.7] [Reference Citation Analysis]
84 Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol 2010; 1(2): 69-84 [PMID: 21607144 DOI: 10.4291/wjgp.v1.i2.69] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]